Follow
Robert Hills
Robert Hills
Verified email at ndph.ox.ac.uk - Homepage
Title
Cited by
Cited by
Year
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.
M Clarke, R Collins, S Darby, C Davies, P Elphinstone, E Evans, ...
Lancet 366 (9503), 2087, 2005
61412005
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger …
D Grimwade, RK Hills, AV Moorman, H Walker, S Chatters, AH Goldstone, ...
Blood, The Journal of the American Society of Hematology 116 (3), 354-365, 2010
21572010
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
Quasar Collaborative Group
The Lancet 370 (9604), 2020-2029, 2007
16482007
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial
AD2000 Collaborative Group
The Lancet 363 (9427), 2105-2115, 2004
11752004
Association between premature mortality and hypopituitarism
JW Tomlinson, N Holden, RK Hills, K Wheatley, RN Clayton, AS Bates, ...
The Lancet 357 (9254), 425-431, 2001
11742001
Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials
Colorectal Cancer Collaborative Group
The Lancet 358 (9290), 1291-1304, 2001
11142001
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ...
Blood, The Journal of the American Society of Hematology 131 (12), 1275-1291, 2018
10432018
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute …
RE Gale, C Green, C Allen, AJ Mead, AK Burnett, RK Hills, DC Linch
Blood, The Journal of the American Society of Hematology 111 (5), 2776-2784, 2008
9502008
Donepezil and memantine for moderate-to-severe Alzheimer's disease
R Howard, R McShane, J Lindesay, C Ritchie, A Baldwin, R Barber, ...
New England Journal of Medicine 366 (10), 893-903, 2012
8972012
Assessment of minimal residual disease in standard-risk AML
A Ivey, RK Hills, MA Simpson, JV Jovanovic, A Gilkes, A Grech, Y Patel, ...
New England Journal of Medicine 374 (5), 422-433, 2016
8542016
Factors predisposing women to chronic pelvic pain: systematic review
P Latthe, L Mignini, R Gray, R Hills, K Khan
Bmj 332 (7544), 749-755, 2006
8512006
A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not …
AK Burnett, D Milligan, AG Prentice, AH Goldstone, MF McMullin, RK Hills, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2007
7472007
Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial
AK Burnett, RK Hills, D Milligan, L Kjeldsen, J Kell, NH Russell, JAL Yin, ...
Journal of clinical oncology 29 (4), 369-377, 2011
7372011
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised …
RK Hills, S Castaigne, FR Appelbaum, J Delaunay, S Petersdorf, M Othus, ...
The lancet oncology 15 (9), 986-996, 2014
7192014
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized WT1 Assay to Enhance Risk Stratification in Acute …
D Cilloni, A Renneville, F Hermitte, RK Hills, S Daly, JV Jovanovic, ...
Journal of Clinical Oncology 27 (31), 5195-5201, 2009
5262009
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
AK Burnett, NH Russell, RK Hills, D Bowen, J Kell, S Knapper, YG Morgan, ...
The lancet oncology 16 (13), 1295-1305, 2015
5022015
Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 …
JAL Yin, MA O'Brien, RK Hills, SB Daly, K Wheatley, AK Burnett
Blood, The Journal of the American Society of Hematology 120 (14), 2826-2835, 2012
4632012
Addition of gemtuzumab ozogamicin to induction chemotherapy improves survival in older patients with acute myeloid leukemia
AK Burnett, NH Russell, RK Hills, J Kell, S Freeman, L Kjeldsen, ...
J Clin Oncol 30 (32), 3924-3931, 2012
4502012
Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial
AK Burnett, NH Russell, RK Hills, AE Hunter, L Kjeldsen, J Yin, ...
Journal of clinical oncology 31 (27), 3360-3368, 2013
4452013
Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine …
Stem Cell Trialists’ Collaborative Group
Journal of clinical oncology: official journal of the American Society of …, 2005
4452005
The system can't perform the operation now. Try again later.
Articles 1–20